Cargando…
Assessment of artemisinin tolerance in Plasmodium falciparum clinical isolates in children with uncomplicated malaria in Ghana
BACKGROUND: Artemisinin-based combination therapy (ACT) is the first-line treatment for uncomplicated malaria in Ghana. Artemisinin (ART) tolerance in Plasmodium falciparum has arisen in Southeast Asia and recently, in parts of East Africa. This is ascribed to the survival of ring-stage parasites po...
Autores principales: | Ahorhorlu, Samuel Yao, Quashie, Neils Ben, Jensen, Rasmus Weisel, Kudzi, William, Nartey, Edmund Tetteh, Duah-Quashie, Nancy Odurowah, Zoiku, Felix, Dzudzor, Bartholomew, Wang, Christian William, Hansson, Helle, Alifrangis, Michael, Adjei, George Obeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938975/ https://www.ncbi.nlm.nih.gov/pubmed/36803541 http://dx.doi.org/10.1186/s12936-023-04482-w |
Ejemplares similares
-
Trends and predictive factors for treatment failure following artemisinin-based combination therapy among children with uncomplicated malaria in Ghana: 2005–2018
por: Abuaku, Benjamin, et al.
Publicado: (2021) -
Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana
por: Abuaku, Benjamin, et al.
Publicado: (2023) -
Genetic polymorphisms of patients on stable warfarin maintenance therapy in a Ghanaian population
por: Kudzi, William, et al.
Publicado: (2016) -
Assessing the Roles of Molecular Markers of Antimalarial Drug Resistance and the Host Pharmacogenetics in Drug-Resistant Malaria
por: Hodoameda, Peter, et al.
Publicado: (2022) -
Plasmodium falciparum genetic factors rather than host factors are likely to drive resistance to ACT in Ghana
por: Hodoameda, Peter, et al.
Publicado: (2020)